HCG vs Sermorelin: How These Two Injectable Hormones Differ

HCG and sermorelin are both injectable hormones used off-label for hormone optimization and body composition, but they act on completely different systems. HCG mimics luteinizing hormone (LH) and signals the testes to produce testosterone, while sermorelin is a growth hormone-releasing hormone (GHRH) analog that prompts the pituitary to release more growth hormone. The right choice depends on whether your goal involves the gonadal axis or the growth hormone axis, not on which compound is "stronger."

What HCG Does in the Body

Human chorionic gonadotropin is a glycoprotein hormone that occurs naturally during pregnancy and is also manufactured as a prescription drug. In men, it binds to the same receptors as LH and stimulates Leydig cells inside the testes.

• Testosterone production: HCG tells the testes to make testosterone, which is why it is often paired with testosterone replacement therapy.
• Testicular volume: Men on long-term testosterone therapy can experience testicular shrinkage; HCG may help preserve size and function.
• Fertility: HCG appears in fertility protocols to support sperm production, sometimes alongside follicle-stimulating hormone.

HCG is FDA-approved for specific conditions, including hypogonadotropic hypogonadism, undescended testes in boys, and ovulation induction in women. It is not approved for weight loss, and the FDA has warned consumers about over-the-counter "hCG diet" products that claim otherwise.

HCG raises testosterone by acting on the testes; it does not increase growth hormone or IGF-1.

What Sermorelin Does in the Body

Sermorelin is a synthetic 29-amino-acid peptide that copies the first portion of naturally occurring GHRH. Instead of supplying a hormone directly, it asks the pituitary to release the body's own growth hormone in pulses.

• Pituitary signaling: Sermorelin binds GHRH receptors on the pituitary and triggers growth hormone release.
• IGF-1: The liver converts much of that growth hormone into IGF-1, the marker most clinicians track.
• Feedback limits: Because it works through the body's own feedback loops, sermorelin cannot push growth hormone as high as direct GH injections can.

Sermorelin was FDA-approved as Geref for evaluating and treating growth hormone deficiency in children, but that product was discontinued in the United States. Today it is mainly obtained through compounding pharmacies and prescribed off-label for adults.

Sermorelin does not raise testosterone or affect sperm production, and HCG does not raise IGF-1.

HCG vs Sermorelin at a Glance

Feature	HCG	Sermorelin
Primary target	Testes (LH receptors)	Pituitary (GHRH receptors)
Hormones affected	Testosterone, estradiol, sperm production	Growth hormone, IGF-1
Typical off-label dose	500–1,000 IU, 2–3 times weekly	100–300 mcg nightly
Injection frequency	2–3 times per week	Daily, usually at bedtime
FDA status	Approved for specific diagnoses; off-label for TRT support	Brand product discontinued; compounded and off-label
Common side effects	Acne, water retention, gynecomastia, mood changes	Injection site reaction, flushing, headache, drowsiness
Key labs	Total and free testosterone, estradiol, hematocrit, PSA	IGF-1, fasting glucose, liver enzymes

Dosing and Injection Schedules

Both drugs are given as small subcutaneous injections, but the timing logic behind each one is different.

HCG is dosed to keep the testes stimulated. TRT support protocols commonly use 500 to 1,000 IU two or three times per week, while fertility protocols may run 1,500 to 3,000 IU several times weekly under close supervision. More is not better here — higher doses tend to raise estradiol and side effects quickly.

Sermorelin is dosed to mimic the body's largest natural growth hormone pulse, which happens during deep sleep. A typical adult protocol is 100 to 300 mcg injected 30 to 60 minutes before bed, five to seven nights per week. Progress is judged by IGF-1 levels over weeks, not days.

Side Effects and Safety Considerations

Neither compound is risk-free, and both require a prescription plus regular blood work.

• HCG: Elevated estradiol can cause breast tenderness, gynecomastia, water retention, and irritability. Rare but serious risks include ovarian hyperstimulation syndrome in women and blood clots.
• Sermorelin: Most complaints are mild — redness at the injection site, facial flushing, headache, and sleepiness shortly after dosing. Sustained growth hormone stimulation can affect blood sugar and fluid balance.
• Both: Gray-market products with inaccurate labels are a genuine hazard, and purity often does not match what the vial claims.

Neither HCG nor sermorelin is FDA-approved for general anti-aging, muscle building, or weight loss in healthy adults. Anyone considering either one should speak with a licensed healthcare professional and confirm baseline labs first.

Where Other Peptides Fit into the Comparison

People comparing HCG and sermorelin often arrive from a broader search for peptide options, and the same questions surface around sermorelin vs aod 9604 and aod 9604 vs hcg. AOD 9604 is a modified fragment of growth hormone that targets fat metabolism and does not meaningfully raise growth hormone, IGF-1, or testosterone, so it sits in a different category than either compound discussed above.

Inside the growth hormone family, cjc-1295 vs sermorelin is one of the most common head-to-head comparisons. CJC-1295 is a longer-acting GHRH analog that stays active far longer, while sermorelin clears the bloodstream within minutes and produces a shorter, more natural pulse. That difference is why stacking discussions — ipamorelin cjc 1295 vs sermorelin, for example — focus on how long the pituitary stays stimulated rather than on raw hormone output.

Tesamorelin is the one GHRH analog with a current FDA approval, for reducing visceral fat in adults with HIV-associated lipodystrophy. That makes comparisons such as tesamorelin vs sermorelin vs cjc-1295 more about approved indications and cost than about potency. Forum posts are not a substitute for a clinician, labs, and a documented plan.

The Bottom Line

HCG and sermorelin solve different problems. HCG is the relevant option when the goal is supporting testosterone production, testicular function, or fertility. Sermorelin is the relevant option when the goal is nudging the body's own growth hormone and IGF-1 output. Neither replaces a proper diagnosis, and neither should be used without medical oversight.

COMMON QUESTIONS

Frequently Asked Questions

Does sermorelin increase testosterone like HCG does?

No. Sermorelin stimulates growth hormone and IGF-1 through the pituitary, while HCG raises testosterone by acting directly on the testes. If testosterone is the goal, sermorelin will not move that number in any meaningful way.

Can you take HCG and sermorelin at the same time?

They act on separate pathways, so some clinicians do combine them, but there is no strong evidence that stacking improves outcomes. Combining two injectable hormones increases cost, injection burden, and the number of side effects to monitor. Any combination should be supervised with regular blood work.

Is HCG or sermorelin FDA-approved for weight loss?

Neither one is approved for weight loss. HCG is approved for specific fertility and endocrine diagnoses, and the FDA has warned against over-the-counter hCG diet products. Sermorelin's brand-name product was discontinued in the US, and compounded sermorelin is prescribed off-label.